AEterna Zentaris Inc. (AEZS)

[iwant1mil]

Huge news last week, why's AEZS going down? This thing should be riding $1.00 by now. We're talking millions of $$ coming soon.

QUÉBEC CITY, Dec. 1, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (AEZS) (AEZ.TO) (the "Company") and Sinopharm A-Think Pharmaceuticals Co., Ltd. ("SinopharmA-Think") today announced the signing of an exclusive license and technology transfer agreement, for the Company's lead anti-cancer compound, zoptarelin doxorubicin, for the initial indication of endometrial cancer, for the Chinese, Hong Kong and Macau markets (the "Territory"). Zoptarelin doxorubicin, a novel synthetic peptide carrier linked to doxorubicin, is currently in a ZoptEC (Zoptarelin doxorubicin in Endometrial Cancer) Phase 3 trial in endometrial cancer.

About Sinopharm A-Think Pharmaceuticals Co., Ltd. ("SinopharmA-Think")

China National Pharmaceutical Group Corporation ("Sinopharm") is the largest medical and healthcare group in China and on the Global Fortune 500 list, which is directly managed by the State-owned Assets Supervision and Administration Commission of the State Council ("SASAC"), with the core businesses of distribution, logistics, retail, scientific research and manufacturing of healthcare related products. In 2013, the gross revenue of Sinopharm exceeded $33.3 billion. For more information, visit www.sinopharm.com.